Global Recombinant FSH Injections Market Growth 2026-2032
The global Recombinant FSH Injections market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
LP Information, Inc. (LPI) ' newest research report, the ?Recombinant FSH Injections Industry Forecast? looks at past sales and reviews total world Recombinant FSH Injections sales in 2025, providing a comprehensive analysis by region and market sector of projected Recombinant FSH Injections sales for 2026 through 2032. With Recombinant FSH Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant FSH Injections industry.
This Insight Report provides a comprehensive analysis of the global Recombinant FSH Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant FSH Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Recombinant FSH Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant FSH Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant FSH Injections.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant FSH Injections market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
LP Information, Inc. (LPI) ' newest research report, the ?Recombinant FSH Injections Industry Forecast? looks at past sales and reviews total world Recombinant FSH Injections sales in 2025, providing a comprehensive analysis by region and market sector of projected Recombinant FSH Injections sales for 2026 through 2032. With Recombinant FSH Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant FSH Injections industry.
This Insight Report provides a comprehensive analysis of the global Recombinant FSH Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant FSH Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Recombinant FSH Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant FSH Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant FSH Injections.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant FSH Injections market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Powder
- Liquid
- IVF and Embryo Transfer
- Infertility Treatment
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gonal-F (Merck)
- Follistim (Organon)
- Bravelle (Ferring)
- Menopur (Ferring)
- Fostimon (IBSA)
- Puregon (Organon)
- BEMFOLA (Gedeon Richter)
- Follitrope (LG Chem)
- GenSci
- What is the 10-year outlook for the global Recombinant FSH Injections market?
- What factors are driving Recombinant FSH Injections market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Recombinant FSH Injections market opportunities vary by end market size?
- How does Recombinant FSH Injections break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant FSH Injections Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Recombinant FSH Injections by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Recombinant FSH Injections by Country/Region, 2021, 2025 & 2032
2.2 Recombinant FSH Injections Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Recombinant FSH Injections Sales by Type
2.2.3.1 Global Recombinant FSH Injections Sales Market Share by Type (2021-2026)
2.2.3.2 Global Recombinant FSH Injections Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Recombinant FSH Injections Sale Price by Type (2021-2026)
2.3 Recombinant FSH Injections Segment by Application
2.3.1 IVF and Embryo Transfer
2.3.2 Infertility Treatment
2.3.3 Recombinant FSH Injections Sales by Application
2.3.3.1 Global Recombinant FSH Injections Sale Market Share by Application (2021-2026)
2.3.3.2 Global Recombinant FSH Injections Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Recombinant FSH Injections Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Recombinant FSH Injections Breakdown Data by Company
3.1.1 Global Recombinant FSH Injections Annual Sales by Company (2021-2026)
3.1.2 Global Recombinant FSH Injections Sales Market Share by Company (2021-2026)
3.2 Global Recombinant FSH Injections Annual Revenue by Company (2021-2026)
3.2.1 Global Recombinant FSH Injections Revenue by Company (2021-2026)
3.2.2 Global Recombinant FSH Injections Revenue Market Share by Company (2021-2026)
3.3 Global Recombinant FSH Injections Sale Price by Company
3.4 Key Manufacturers Recombinant FSH Injections Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant FSH Injections Product Location Distribution
3.4.2 Players Recombinant FSH Injections Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RECOMBINANT FSH INJECTIONS BY GEOGRAPHIC REGION
4.1 World Historic Recombinant FSH Injections Market Size by Geographic Region (2021-2026)
4.1.1 Global Recombinant FSH Injections Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Recombinant FSH Injections Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Recombinant FSH Injections Market Size by Country/Region (2021-2026)
4.2.1 Global Recombinant FSH Injections Annual Sales by Country/Region (2021-2026)
4.2.2 Global Recombinant FSH Injections Annual Revenue by Country/Region (2021-2026)
4.3 Americas Recombinant FSH Injections Sales Growth
4.4 APAC Recombinant FSH Injections Sales Growth
4.5 Europe Recombinant FSH Injections Sales Growth
4.6 Middle East & Africa Recombinant FSH Injections Sales Growth
5 AMERICAS
5.1 Americas Recombinant FSH Injections Sales by Country
5.1.1 Americas Recombinant FSH Injections Sales by Country (2021-2026)
5.1.2 Americas Recombinant FSH Injections Revenue by Country (2021-2026)
5.2 Americas Recombinant FSH Injections Sales by Type (2021-2026)
5.3 Americas Recombinant FSH Injections Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant FSH Injections Sales by Region
6.1.1 APAC Recombinant FSH Injections Sales by Region (2021-2026)
6.1.2 APAC Recombinant FSH Injections Revenue by Region (2021-2026)
6.2 APAC Recombinant FSH Injections Sales by Type (2021-2026)
6.3 APAC Recombinant FSH Injections Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant FSH Injections by Country
7.1.1 Europe Recombinant FSH Injections Sales by Country (2021-2026)
7.1.2 Europe Recombinant FSH Injections Revenue by Country (2021-2026)
7.2 Europe Recombinant FSH Injections Sales by Type (2021-2026)
7.3 Europe Recombinant FSH Injections Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant FSH Injections by Country
8.1.1 Middle East & Africa Recombinant FSH Injections Sales by Country (2021-2026)
8.1.2 Middle East & Africa Recombinant FSH Injections Revenue by Country (2021-2026)
8.2 Middle East & Africa Recombinant FSH Injections Sales by Type (2021-2026)
8.3 Middle East & Africa Recombinant FSH Injections Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant FSH Injections
10.3 Manufacturing Process Analysis of Recombinant FSH Injections
10.4 Industry Chain Structure of Recombinant FSH Injections
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant FSH Injections Distributors
11.3 Recombinant FSH Injections Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT FSH INJECTIONS BY GEOGRAPHIC REGION
12.1 Global Recombinant FSH Injections Market Size Forecast by Region
12.1.1 Global Recombinant FSH Injections Forecast by Region (2027-2032)
12.1.2 Global Recombinant FSH Injections Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Recombinant FSH Injections Forecast by Type (2027-2032)
12.7 Global Recombinant FSH Injections Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Gonal-F (Merck)
13.1.1 Gonal-F (Merck) Company Information
13.1.2 Gonal-F (Merck) Recombinant FSH Injections Product Portfolios and Specifications
13.1.3 Gonal-F (Merck) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Gonal-F (Merck) Main Business Overview
13.1.5 Gonal-F (Merck) Latest Developments
13.2 Follistim (Organon)
13.2.1 Follistim (Organon) Company Information
13.2.2 Follistim (Organon) Recombinant FSH Injections Product Portfolios and Specifications
13.2.3 Follistim (Organon) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Follistim (Organon) Main Business Overview
13.2.5 Follistim (Organon) Latest Developments
13.3 Bravelle (Ferring)
13.3.1 Bravelle (Ferring) Company Information
13.3.2 Bravelle (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
13.3.3 Bravelle (Ferring) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bravelle (Ferring) Main Business Overview
13.3.5 Bravelle (Ferring) Latest Developments
13.4 Menopur (Ferring)
13.4.1 Menopur (Ferring) Company Information
13.4.2 Menopur (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
13.4.3 Menopur (Ferring) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Menopur (Ferring) Main Business Overview
13.4.5 Menopur (Ferring) Latest Developments
13.5 Fostimon (IBSA)
13.5.1 Fostimon (IBSA) Company Information
13.5.2 Fostimon (IBSA) Recombinant FSH Injections Product Portfolios and Specifications
13.5.3 Fostimon (IBSA) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Fostimon (IBSA) Main Business Overview
13.5.5 Fostimon (IBSA) Latest Developments
13.6 Puregon (Organon)
13.6.1 Puregon (Organon) Company Information
13.6.2 Puregon (Organon) Recombinant FSH Injections Product Portfolios and Specifications
13.6.3 Puregon (Organon) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Puregon (Organon) Main Business Overview
13.6.5 Puregon (Organon) Latest Developments
13.7 BEMFOLA (Gedeon Richter)
13.7.1 BEMFOLA (Gedeon Richter) Company Information
13.7.2 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolios and Specifications
13.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BEMFOLA (Gedeon Richter) Main Business Overview
13.7.5 BEMFOLA (Gedeon Richter) Latest Developments
13.8 Follitrope (LG Chem)
13.8.1 Follitrope (LG Chem) Company Information
13.8.2 Follitrope (LG Chem) Recombinant FSH Injections Product Portfolios and Specifications
13.8.3 Follitrope (LG Chem) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Follitrope (LG Chem) Main Business Overview
13.8.5 Follitrope (LG Chem) Latest Developments
13.9 GenSci
13.9.1 GenSci Company Information
13.9.2 GenSci Recombinant FSH Injections Product Portfolios and Specifications
13.9.3 GenSci Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GenSci Main Business Overview
13.9.5 GenSci Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant FSH Injections Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Recombinant FSH Injections by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Recombinant FSH Injections by Country/Region, 2021, 2025 & 2032
2.2 Recombinant FSH Injections Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Recombinant FSH Injections Sales by Type
2.2.3.1 Global Recombinant FSH Injections Sales Market Share by Type (2021-2026)
2.2.3.2 Global Recombinant FSH Injections Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Recombinant FSH Injections Sale Price by Type (2021-2026)
2.3 Recombinant FSH Injections Segment by Application
2.3.1 IVF and Embryo Transfer
2.3.2 Infertility Treatment
2.3.3 Recombinant FSH Injections Sales by Application
2.3.3.1 Global Recombinant FSH Injections Sale Market Share by Application (2021-2026)
2.3.3.2 Global Recombinant FSH Injections Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Recombinant FSH Injections Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Recombinant FSH Injections Breakdown Data by Company
3.1.1 Global Recombinant FSH Injections Annual Sales by Company (2021-2026)
3.1.2 Global Recombinant FSH Injections Sales Market Share by Company (2021-2026)
3.2 Global Recombinant FSH Injections Annual Revenue by Company (2021-2026)
3.2.1 Global Recombinant FSH Injections Revenue by Company (2021-2026)
3.2.2 Global Recombinant FSH Injections Revenue Market Share by Company (2021-2026)
3.3 Global Recombinant FSH Injections Sale Price by Company
3.4 Key Manufacturers Recombinant FSH Injections Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant FSH Injections Product Location Distribution
3.4.2 Players Recombinant FSH Injections Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RECOMBINANT FSH INJECTIONS BY GEOGRAPHIC REGION
4.1 World Historic Recombinant FSH Injections Market Size by Geographic Region (2021-2026)
4.1.1 Global Recombinant FSH Injections Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Recombinant FSH Injections Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Recombinant FSH Injections Market Size by Country/Region (2021-2026)
4.2.1 Global Recombinant FSH Injections Annual Sales by Country/Region (2021-2026)
4.2.2 Global Recombinant FSH Injections Annual Revenue by Country/Region (2021-2026)
4.3 Americas Recombinant FSH Injections Sales Growth
4.4 APAC Recombinant FSH Injections Sales Growth
4.5 Europe Recombinant FSH Injections Sales Growth
4.6 Middle East & Africa Recombinant FSH Injections Sales Growth
5 AMERICAS
5.1 Americas Recombinant FSH Injections Sales by Country
5.1.1 Americas Recombinant FSH Injections Sales by Country (2021-2026)
5.1.2 Americas Recombinant FSH Injections Revenue by Country (2021-2026)
5.2 Americas Recombinant FSH Injections Sales by Type (2021-2026)
5.3 Americas Recombinant FSH Injections Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant FSH Injections Sales by Region
6.1.1 APAC Recombinant FSH Injections Sales by Region (2021-2026)
6.1.2 APAC Recombinant FSH Injections Revenue by Region (2021-2026)
6.2 APAC Recombinant FSH Injections Sales by Type (2021-2026)
6.3 APAC Recombinant FSH Injections Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant FSH Injections by Country
7.1.1 Europe Recombinant FSH Injections Sales by Country (2021-2026)
7.1.2 Europe Recombinant FSH Injections Revenue by Country (2021-2026)
7.2 Europe Recombinant FSH Injections Sales by Type (2021-2026)
7.3 Europe Recombinant FSH Injections Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant FSH Injections by Country
8.1.1 Middle East & Africa Recombinant FSH Injections Sales by Country (2021-2026)
8.1.2 Middle East & Africa Recombinant FSH Injections Revenue by Country (2021-2026)
8.2 Middle East & Africa Recombinant FSH Injections Sales by Type (2021-2026)
8.3 Middle East & Africa Recombinant FSH Injections Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant FSH Injections
10.3 Manufacturing Process Analysis of Recombinant FSH Injections
10.4 Industry Chain Structure of Recombinant FSH Injections
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant FSH Injections Distributors
11.3 Recombinant FSH Injections Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT FSH INJECTIONS BY GEOGRAPHIC REGION
12.1 Global Recombinant FSH Injections Market Size Forecast by Region
12.1.1 Global Recombinant FSH Injections Forecast by Region (2027-2032)
12.1.2 Global Recombinant FSH Injections Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Recombinant FSH Injections Forecast by Type (2027-2032)
12.7 Global Recombinant FSH Injections Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Gonal-F (Merck)
13.1.1 Gonal-F (Merck) Company Information
13.1.2 Gonal-F (Merck) Recombinant FSH Injections Product Portfolios and Specifications
13.1.3 Gonal-F (Merck) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Gonal-F (Merck) Main Business Overview
13.1.5 Gonal-F (Merck) Latest Developments
13.2 Follistim (Organon)
13.2.1 Follistim (Organon) Company Information
13.2.2 Follistim (Organon) Recombinant FSH Injections Product Portfolios and Specifications
13.2.3 Follistim (Organon) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Follistim (Organon) Main Business Overview
13.2.5 Follistim (Organon) Latest Developments
13.3 Bravelle (Ferring)
13.3.1 Bravelle (Ferring) Company Information
13.3.2 Bravelle (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
13.3.3 Bravelle (Ferring) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bravelle (Ferring) Main Business Overview
13.3.5 Bravelle (Ferring) Latest Developments
13.4 Menopur (Ferring)
13.4.1 Menopur (Ferring) Company Information
13.4.2 Menopur (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
13.4.3 Menopur (Ferring) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Menopur (Ferring) Main Business Overview
13.4.5 Menopur (Ferring) Latest Developments
13.5 Fostimon (IBSA)
13.5.1 Fostimon (IBSA) Company Information
13.5.2 Fostimon (IBSA) Recombinant FSH Injections Product Portfolios and Specifications
13.5.3 Fostimon (IBSA) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Fostimon (IBSA) Main Business Overview
13.5.5 Fostimon (IBSA) Latest Developments
13.6 Puregon (Organon)
13.6.1 Puregon (Organon) Company Information
13.6.2 Puregon (Organon) Recombinant FSH Injections Product Portfolios and Specifications
13.6.3 Puregon (Organon) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Puregon (Organon) Main Business Overview
13.6.5 Puregon (Organon) Latest Developments
13.7 BEMFOLA (Gedeon Richter)
13.7.1 BEMFOLA (Gedeon Richter) Company Information
13.7.2 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolios and Specifications
13.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BEMFOLA (Gedeon Richter) Main Business Overview
13.7.5 BEMFOLA (Gedeon Richter) Latest Developments
13.8 Follitrope (LG Chem)
13.8.1 Follitrope (LG Chem) Company Information
13.8.2 Follitrope (LG Chem) Recombinant FSH Injections Product Portfolios and Specifications
13.8.3 Follitrope (LG Chem) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Follitrope (LG Chem) Main Business Overview
13.8.5 Follitrope (LG Chem) Latest Developments
13.9 GenSci
13.9.1 GenSci Company Information
13.9.2 GenSci Recombinant FSH Injections Product Portfolios and Specifications
13.9.3 GenSci Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GenSci Main Business Overview
13.9.5 GenSci Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant FSH Injections Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Recombinant FSH Injections Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 6. Global Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Table 7. Global Recombinant FSH Injections Revenue by Type (2021-2026) & ($ million)
Table 8. Global Recombinant FSH Injections Revenue Market Share by Type (2021-2026)
Table 9. Global Recombinant FSH Injections Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Recombinant FSH Injections Sale by Application (2021-2026) & (K Units)
Table 11. Global Recombinant FSH Injections Sale Market Share by Application (2021-2026)
Table 12. Global Recombinant FSH Injections Revenue by Application (2021-2026) & ($ million)
Table 13. Global Recombinant FSH Injections Revenue Market Share by Application (2021-2026)
Table 14. Global Recombinant FSH Injections Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Recombinant FSH Injections Sales by Company (2021-2026) & (K Units)
Table 16. Global Recombinant FSH Injections Sales Market Share by Company (2021-2026)
Table 17. Global Recombinant FSH Injections Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Recombinant FSH Injections Revenue Market Share by Company (2021-2026)
Table 19. Global Recombinant FSH Injections Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Recombinant FSH Injections Producing Area Distribution and Sales Area
Table 21. Players Recombinant FSH Injections Products Offered
Table 22. Recombinant FSH Injections Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Recombinant FSH Injections Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Recombinant FSH Injections Sales Market Share Geographic Region (2021-2026)
Table 27. Global Recombinant FSH Injections Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Recombinant FSH Injections Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Recombinant FSH Injections Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Recombinant FSH Injections Sales Market Share by Country/Region (2021-2026)
Table 31. Global Recombinant FSH Injections Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Recombinant FSH Injections Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Recombinant FSH Injections Sales by Country (2021-2026) & (K Units)
Table 34. Americas Recombinant FSH Injections Sales Market Share by Country (2021-2026)
Table 35. Americas Recombinant FSH Injections Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 37. Americas Recombinant FSH Injections Sales by Application (2021-2026) & (K Units)
Table 38. APAC Recombinant FSH Injections Sales by Region (2021-2026) & (K Units)
Table 39. APAC Recombinant FSH Injections Sales Market Share by Region (2021-2026)
Table 40. APAC Recombinant FSH Injections Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 42. APAC Recombinant FSH Injections Sales by Application (2021-2026) & (K Units)
Table 43. Europe Recombinant FSH Injections Sales by Country (2021-2026) & (K Units)
Table 44. Europe Recombinant FSH Injections Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 46. Europe Recombinant FSH Injections Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Recombinant FSH Injections Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Recombinant FSH Injections Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Recombinant FSH Injections Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Recombinant FSH Injections
Table 52. Key Market Challenges & Risks of Recombinant FSH Injections
Table 53. Key Industry Trends of Recombinant FSH Injections
Table 54. Recombinant FSH Injections Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Recombinant FSH Injections Distributors List
Table 57. Recombinant FSH Injections Customer List
Table 58. Global Recombinant FSH Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Recombinant FSH Injections Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Recombinant FSH Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Recombinant FSH Injections Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Recombinant FSH Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Recombinant FSH Injections Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Recombinant FSH Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Recombinant FSH Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Recombinant FSH Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Recombinant FSH Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Recombinant FSH Injections Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Recombinant FSH Injections Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Recombinant FSH Injections Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Recombinant FSH Injections Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Gonal-F (Merck) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 73. Gonal-F (Merck) Recombinant FSH Injections Product Portfolios and Specifications
Table 74. Gonal-F (Merck) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Gonal-F (Merck) Main Business
Table 76. Gonal-F (Merck) Latest Developments
Table 77. Follistim (Organon) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 78. Follistim (Organon) Recombinant FSH Injections Product Portfolios and Specifications
Table 79. Follistim (Organon) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Follistim (Organon) Main Business
Table 81. Follistim (Organon) Latest Developments
Table 82. Bravelle (Ferring) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 83. Bravelle (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
Table 84. Bravelle (Ferring) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Bravelle (Ferring) Main Business
Table 86. Bravelle (Ferring) Latest Developments
Table 87. Menopur (Ferring) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 88. Menopur (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
Table 89. Menopur (Ferring) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Menopur (Ferring) Main Business
Table 91. Menopur (Ferring) Latest Developments
Table 92. Fostimon (IBSA) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 93. Fostimon (IBSA) Recombinant FSH Injections Product Portfolios and Specifications
Table 94. Fostimon (IBSA) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Fostimon (IBSA) Main Business
Table 96. Fostimon (IBSA) Latest Developments
Table 97. Puregon (Organon) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 98. Puregon (Organon) Recombinant FSH Injections Product Portfolios and Specifications
Table 99. Puregon (Organon) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Puregon (Organon) Main Business
Table 101. Puregon (Organon) Latest Developments
Table 102. BEMFOLA (Gedeon Richter) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 103. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolios and Specifications
Table 104. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. BEMFOLA (Gedeon Richter) Main Business
Table 106. BEMFOLA (Gedeon Richter) Latest Developments
Table 107. Follitrope (LG Chem) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 108. Follitrope (LG Chem) Recombinant FSH Injections Product Portfolios and Specifications
Table 109. Follitrope (LG Chem) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Follitrope (LG Chem) Main Business
Table 111. Follitrope (LG Chem) Latest Developments
Table 112. GenSci Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 113. GenSci Recombinant FSH Injections Product Portfolios and Specifications
Table 114. GenSci Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. GenSci Main Business
Table 116. GenSci Latest Developments
Table 1. Recombinant FSH Injections Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Recombinant FSH Injections Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 6. Global Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Table 7. Global Recombinant FSH Injections Revenue by Type (2021-2026) & ($ million)
Table 8. Global Recombinant FSH Injections Revenue Market Share by Type (2021-2026)
Table 9. Global Recombinant FSH Injections Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Recombinant FSH Injections Sale by Application (2021-2026) & (K Units)
Table 11. Global Recombinant FSH Injections Sale Market Share by Application (2021-2026)
Table 12. Global Recombinant FSH Injections Revenue by Application (2021-2026) & ($ million)
Table 13. Global Recombinant FSH Injections Revenue Market Share by Application (2021-2026)
Table 14. Global Recombinant FSH Injections Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Recombinant FSH Injections Sales by Company (2021-2026) & (K Units)
Table 16. Global Recombinant FSH Injections Sales Market Share by Company (2021-2026)
Table 17. Global Recombinant FSH Injections Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Recombinant FSH Injections Revenue Market Share by Company (2021-2026)
Table 19. Global Recombinant FSH Injections Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Recombinant FSH Injections Producing Area Distribution and Sales Area
Table 21. Players Recombinant FSH Injections Products Offered
Table 22. Recombinant FSH Injections Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Recombinant FSH Injections Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Recombinant FSH Injections Sales Market Share Geographic Region (2021-2026)
Table 27. Global Recombinant FSH Injections Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Recombinant FSH Injections Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Recombinant FSH Injections Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Recombinant FSH Injections Sales Market Share by Country/Region (2021-2026)
Table 31. Global Recombinant FSH Injections Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Recombinant FSH Injections Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Recombinant FSH Injections Sales by Country (2021-2026) & (K Units)
Table 34. Americas Recombinant FSH Injections Sales Market Share by Country (2021-2026)
Table 35. Americas Recombinant FSH Injections Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 37. Americas Recombinant FSH Injections Sales by Application (2021-2026) & (K Units)
Table 38. APAC Recombinant FSH Injections Sales by Region (2021-2026) & (K Units)
Table 39. APAC Recombinant FSH Injections Sales Market Share by Region (2021-2026)
Table 40. APAC Recombinant FSH Injections Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 42. APAC Recombinant FSH Injections Sales by Application (2021-2026) & (K Units)
Table 43. Europe Recombinant FSH Injections Sales by Country (2021-2026) & (K Units)
Table 44. Europe Recombinant FSH Injections Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 46. Europe Recombinant FSH Injections Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Recombinant FSH Injections Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Recombinant FSH Injections Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Recombinant FSH Injections Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Recombinant FSH Injections Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Recombinant FSH Injections
Table 52. Key Market Challenges & Risks of Recombinant FSH Injections
Table 53. Key Industry Trends of Recombinant FSH Injections
Table 54. Recombinant FSH Injections Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Recombinant FSH Injections Distributors List
Table 57. Recombinant FSH Injections Customer List
Table 58. Global Recombinant FSH Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Recombinant FSH Injections Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Recombinant FSH Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Recombinant FSH Injections Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Recombinant FSH Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Recombinant FSH Injections Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Recombinant FSH Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Recombinant FSH Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Recombinant FSH Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Recombinant FSH Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Recombinant FSH Injections Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Recombinant FSH Injections Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Recombinant FSH Injections Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Recombinant FSH Injections Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Gonal-F (Merck) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 73. Gonal-F (Merck) Recombinant FSH Injections Product Portfolios and Specifications
Table 74. Gonal-F (Merck) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Gonal-F (Merck) Main Business
Table 76. Gonal-F (Merck) Latest Developments
Table 77. Follistim (Organon) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 78. Follistim (Organon) Recombinant FSH Injections Product Portfolios and Specifications
Table 79. Follistim (Organon) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Follistim (Organon) Main Business
Table 81. Follistim (Organon) Latest Developments
Table 82. Bravelle (Ferring) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 83. Bravelle (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
Table 84. Bravelle (Ferring) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Bravelle (Ferring) Main Business
Table 86. Bravelle (Ferring) Latest Developments
Table 87. Menopur (Ferring) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 88. Menopur (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
Table 89. Menopur (Ferring) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Menopur (Ferring) Main Business
Table 91. Menopur (Ferring) Latest Developments
Table 92. Fostimon (IBSA) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 93. Fostimon (IBSA) Recombinant FSH Injections Product Portfolios and Specifications
Table 94. Fostimon (IBSA) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Fostimon (IBSA) Main Business
Table 96. Fostimon (IBSA) Latest Developments
Table 97. Puregon (Organon) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 98. Puregon (Organon) Recombinant FSH Injections Product Portfolios and Specifications
Table 99. Puregon (Organon) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Puregon (Organon) Main Business
Table 101. Puregon (Organon) Latest Developments
Table 102. BEMFOLA (Gedeon Richter) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 103. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolios and Specifications
Table 104. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. BEMFOLA (Gedeon Richter) Main Business
Table 106. BEMFOLA (Gedeon Richter) Latest Developments
Table 107. Follitrope (LG Chem) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 108. Follitrope (LG Chem) Recombinant FSH Injections Product Portfolios and Specifications
Table 109. Follitrope (LG Chem) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Follitrope (LG Chem) Main Business
Table 111. Follitrope (LG Chem) Latest Developments
Table 112. GenSci Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 113. GenSci Recombinant FSH Injections Product Portfolios and Specifications
Table 114. GenSci Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. GenSci Main Business
Table 116. GenSci Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant FSH Injections
Figure 2. Recombinant FSH Injections Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant FSH Injections Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Recombinant FSH Injections Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Recombinant FSH Injections Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Recombinant FSH Injections Sales Market Share by Country/Region (2025)
Figure 10. Recombinant FSH Injections Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Recombinant FSH Injections Sales Market Share by Type in 2026
Figure 14. Global Recombinant FSH Injections Revenue Market Share by Type (2021-2026)
Figure 15. Recombinant FSH Injections Consumed in IVF and Embryo Transfer
Figure 16. Global Recombinant FSH Injections Market: IVF and Embryo Transfer (2021-2026) & (K Units)
Figure 17. Recombinant FSH Injections Consumed in Infertility Treatment
Figure 18. Global Recombinant FSH Injections Market: Infertility Treatment (2021-2026) & (K Units)
Figure 19. Global Recombinant FSH Injections Sale Market Share by Application (2025)
Figure 20. Global Recombinant FSH Injections Revenue Market Share by Application in 2026
Figure 21. Recombinant FSH Injections Sales by Company in 2026 (K Units)
Figure 22. Global Recombinant FSH Injections Sales Market Share by Company in 2026
Figure 23. Recombinant FSH Injections Revenue by Company in 2026 ($ millions)
Figure 24. Global Recombinant FSH Injections Revenue Market Share by Company in 2026
Figure 25. Global Recombinant FSH Injections Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Recombinant FSH Injections Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Recombinant FSH Injections Sales 2021-2026 (K Units)
Figure 28. Americas Recombinant FSH Injections Revenue 2021-2026 ($ millions)
Figure 29. APAC Recombinant FSH Injections Sales 2021-2026 (K Units)
Figure 30. APAC Recombinant FSH Injections Revenue 2021-2026 ($ millions)
Figure 31. Europe Recombinant FSH Injections Sales 2021-2026 (K Units)
Figure 32. Europe Recombinant FSH Injections Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Recombinant FSH Injections Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Recombinant FSH Injections Revenue 2021-2026 ($ millions)
Figure 35. Americas Recombinant FSH Injections Sales Market Share by Country in 2026
Figure 36. Americas Recombinant FSH Injections Revenue Market Share by Country (2021-2026)
Figure 37. Americas Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Figure 38. Americas Recombinant FSH Injections Sales Market Share by Application (2021-2026)
Figure 39. United States Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Recombinant FSH Injections Sales Market Share by Region in 2026
Figure 44. APAC Recombinant FSH Injections Revenue Market Share by Region (2021-2026)
Figure 45. APAC Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Figure 46. APAC Recombinant FSH Injections Sales Market Share by Application (2021-2026)
Figure 47. China Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 51. India Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Recombinant FSH Injections Sales Market Share by Country in 2026
Figure 55. Europe Recombinant FSH Injections Revenue Market Share by Country (2021-2026)
Figure 56. Europe Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Figure 57. Europe Recombinant FSH Injections Sales Market Share by Application (2021-2026)
Figure 58. Germany Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 59. France Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Recombinant FSH Injections Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Recombinant FSH Injections Sales Market Share by Application (2021-2026)
Figure 66. Egypt Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Recombinant FSH Injections in 2026
Figure 72. Manufacturing Process Analysis of Recombinant FSH Injections
Figure 73. Industry Chain Structure of Recombinant FSH Injections
Figure 74. Channels of Distribution
Figure 75. Global Recombinant FSH Injections Sales Market Forecast by Region (2027-2032)
Figure 76. Global Recombinant FSH Injections Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Recombinant FSH Injections Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Recombinant FSH Injections Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Recombinant FSH Injections Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Recombinant FSH Injections Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Recombinant FSH Injections
Figure 2. Recombinant FSH Injections Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant FSH Injections Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Recombinant FSH Injections Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Recombinant FSH Injections Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Recombinant FSH Injections Sales Market Share by Country/Region (2025)
Figure 10. Recombinant FSH Injections Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Recombinant FSH Injections Sales Market Share by Type in 2026
Figure 14. Global Recombinant FSH Injections Revenue Market Share by Type (2021-2026)
Figure 15. Recombinant FSH Injections Consumed in IVF and Embryo Transfer
Figure 16. Global Recombinant FSH Injections Market: IVF and Embryo Transfer (2021-2026) & (K Units)
Figure 17. Recombinant FSH Injections Consumed in Infertility Treatment
Figure 18. Global Recombinant FSH Injections Market: Infertility Treatment (2021-2026) & (K Units)
Figure 19. Global Recombinant FSH Injections Sale Market Share by Application (2025)
Figure 20. Global Recombinant FSH Injections Revenue Market Share by Application in 2026
Figure 21. Recombinant FSH Injections Sales by Company in 2026 (K Units)
Figure 22. Global Recombinant FSH Injections Sales Market Share by Company in 2026
Figure 23. Recombinant FSH Injections Revenue by Company in 2026 ($ millions)
Figure 24. Global Recombinant FSH Injections Revenue Market Share by Company in 2026
Figure 25. Global Recombinant FSH Injections Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Recombinant FSH Injections Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Recombinant FSH Injections Sales 2021-2026 (K Units)
Figure 28. Americas Recombinant FSH Injections Revenue 2021-2026 ($ millions)
Figure 29. APAC Recombinant FSH Injections Sales 2021-2026 (K Units)
Figure 30. APAC Recombinant FSH Injections Revenue 2021-2026 ($ millions)
Figure 31. Europe Recombinant FSH Injections Sales 2021-2026 (K Units)
Figure 32. Europe Recombinant FSH Injections Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Recombinant FSH Injections Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Recombinant FSH Injections Revenue 2021-2026 ($ millions)
Figure 35. Americas Recombinant FSH Injections Sales Market Share by Country in 2026
Figure 36. Americas Recombinant FSH Injections Revenue Market Share by Country (2021-2026)
Figure 37. Americas Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Figure 38. Americas Recombinant FSH Injections Sales Market Share by Application (2021-2026)
Figure 39. United States Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Recombinant FSH Injections Sales Market Share by Region in 2026
Figure 44. APAC Recombinant FSH Injections Revenue Market Share by Region (2021-2026)
Figure 45. APAC Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Figure 46. APAC Recombinant FSH Injections Sales Market Share by Application (2021-2026)
Figure 47. China Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 51. India Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Recombinant FSH Injections Sales Market Share by Country in 2026
Figure 55. Europe Recombinant FSH Injections Revenue Market Share by Country (2021-2026)
Figure 56. Europe Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Figure 57. Europe Recombinant FSH Injections Sales Market Share by Application (2021-2026)
Figure 58. Germany Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 59. France Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Recombinant FSH Injections Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Recombinant FSH Injections Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Recombinant FSH Injections Sales Market Share by Application (2021-2026)
Figure 66. Egypt Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Recombinant FSH Injections Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Recombinant FSH Injections in 2026
Figure 72. Manufacturing Process Analysis of Recombinant FSH Injections
Figure 73. Industry Chain Structure of Recombinant FSH Injections
Figure 74. Channels of Distribution
Figure 75. Global Recombinant FSH Injections Sales Market Forecast by Region (2027-2032)
Figure 76. Global Recombinant FSH Injections Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Recombinant FSH Injections Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Recombinant FSH Injections Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Recombinant FSH Injections Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Recombinant FSH Injections Revenue Market Share Forecast by Application (2027-2032)
